Platelet transfusion refractoriness associated with HPA-1a (PlA1) alloantibody
without coexistent HLA antibodies successfully treated with antigen-negative platelet transfusions.
Germinal center alloantibody
responses are mediated exclusively by indirect-pathway CD4 T follicular helper cells," Journal of Immunology, vol.
Impact of alloantibody
strength in crossmatch negative DSA positive kidney transplantation.
screening and identification tests were done using the 3 cell panel followed by 11 cell panel of Diamed.
Further laboratory results (direct antiglobulin test and bilirubin) were assessed and reported for five babies whose maternal alloantibody
titre by IAT tube was less than 16, but equal to 16 by CAT.
Immunotoxicity testing showed that there was no treatment-induced alloantibody
formation or induction of autoimmunity.
Maternal anti-K is the second most common alloantibody
(anti-D is the first) and accounts for 10%45% of all patients with antibody-mediated severe hemolytic anemia (2).
hypocalcemia), red blood cell alloantibody
sensitization, transmissible infection, and line sepsis.
Although the protocols for desensitizing a recipient for a positive cross-match living donor do not produce tolerance, the recipient alloantibody
specific for the donor generally does not reappear, in the face of reemergence of the rest of the non-donor-specific antibody after the desensitization treatment is ended.
These false-negative antibody screening results pose a high risk for patients; (13) it has been well documented that the failure to detect weakly reactive red cell alloantibody
can lead to a rapid anamnestic production of antibody and delayed hemolytic transfusion reactions.
Compare and contrast the development of an autoantibody and an alloantibody
specificity and antigen potency in Olmsted County, Minnesota.
After a short incubation, rabbit serum was added as a source of complement, and the cells that had bound the alloantibody
were lysed, making them permeable to the fluorochrome ethidium bromide.
These patients have a high likelihood for developing an alloantibody
following red cell transfusion.
C4d deposition in cardiac allografts correlates with alloantibody